Two retroviruses packaged in one cell line can combined inhibit the replication of HIV-1 in TZM-bl cells

Virologica Sinica

Volumn 27, Issue 6, 2012, Pages 339-344

  Liang, Zhipin ^a   Guo, Zhiyuan ^a   Wang, Xin ^b   Kong, Xiaohong ^a   Liu, Chang ^a  

^a NANKAI UNIVERSITY   (China)

^b Tianjing Centre for Disease Control and Prevention   (China)

Author keywords

Gene therapy; HIV 1; Tetherin; Vpu

Indexed keywords

CELL PROTEIN; RETROVIRUS VECTOR; TETHERIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL STRAIN PT67; CELL STRAIN TZM BI; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PLASMID; RETROVIRUS; RNA INTERFERENCE; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION; VPU GENE;

ANTIGENS, CD; CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION; GPI-LINKED PROTEINS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; PLASMIDS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84875215908     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-012-3263-8     Document Type: Article

References (24)

1. Andrew A J, Miyagi E, Strebel K. 2010. Differential effects of human immunodeficiency virus type 1 vpu on the stability of bst-2/tetherin. J Virol, 85(6): 2611-2619.
2. Douglas J L, Viswanathan K, McCarroll M N, et al. 2009. Vpu directs the degradation of the human immunodeficiency virus restriction factor bst-2/tetherin via a tatrcp-dependent mechanism. J Virol, 83(16): 7931-7947.
3. Goto T, Kennel S J, Abe M, et al. 1994. A novel membrane antigen selectively expressed on terminally differentiated human b cells. Blood, 84(6): 1922-1930. (Pubitemid 24286144)
4. Gupta R K, Mlcochova P, Pelchen-Matthews A, et al. 2009. Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/bst-2/cd317 by intracellular sequestration. Proc Natl Acad Sci U S A, 106(49): 20889-20894.
5. Hauser H, Lopez L A, Yang S J, et al. 2010. Hiv-1 vpu and hiv-2 env counteract bst-2/tetherin by sequestration in a perinuclear compartment. Retrovirology, 7: 51.
6. Ishikawa J, Kaisho T, Tomizawa H, et al. 1995. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, bst2, that may be involved in pre-b-cell growth. Genomics, 26(3): 527-534.
7. Klimkait T, Strebel K, Hoggan M D, et al. 1990. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol, 64(2): 621-629. (Pubitemid 20032674)
8. Kong X, West J T, Zhang H, et al. 2008. The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses. J Virol, 82(23): 11609-11618.
9. Kupzig S, Korolchuk V, Rollason R, et al. 2003. Bst-2/hm1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic, 4(10): 694-709. (Pubitemid 37168591)
10. Le Tortorec A, Willey S, Neil S J. 2011. Antiviral inhibition of enveloped virus release by tetherin/bst-2: Action and counteraction. Viruses, 3(5): 520-540.
11. Liu C, Shi Y J, Xuan C h, et al. 2008. Establishment of an in vitro protein modification system with antiserum against ubiquitin-like modifier bisg15. Chin J Biochem Mol Biol, 24(1): 30-34. (in Chinese)
12. Liu C, Chang R, Yao X, et al. 2009. Isg15 expression in response to double-stranded rna or lps in cultured fetal bovine lung (fbl) cells. Vet Res Commun, 33(7): 723-733.
13. Malim M H, Emerman M. 2008. HIV-1 accessory proteins - ensuring viral survival in a hostile environment. Cell Host Microb, 3(6): 388-398. (Pubitemid 351784365)
14. Miller A D, Chen F. 1996. Retrovirus packaging cells based on 10a1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol, 70(8): 5564-5571. (Pubitemid 26240733)
15. Naito Y, Ui-Tei K, Nishikawa T, et al. 2006. Sivirus: Web-based antiviral sirna design software for highly divergent viral sequences. Nucleic Acids Res, 34(Web Server issue): W448-450. (Pubitemid 44529810)
16. Neil S J, Zang T, Bieniasz P D. 2008. Tetherin inhibits retrovirus release and is antagonized by hiv-1 vpu. Nature, 451(7177): 425-430. (Pubitemid 351158893)
17. Nguyen D H, Hildreth J E. 2000. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol, 74(7): 3264-3272. (Pubitemid 30143751)
18. Platt E J, Bilska M, Kozak S L, et al. 2009. Evidence that ecotropic murine leukemia virus contamination in tzm-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1. J Virol, 83(16): 8289-8292.
19. Reinke S O, Bayer M, Berger M, et al. 2011. Analysis of cell surface n-glycosylation of the human embryonic kidney 293t cell line. J Carbohydr Chem, 30(4-6): 218-232.
20. Salmon P, Trono D. 2006. Design and production of human immunodeficiency virus-derived vectors, In: Cell biology: A laboratory handbook. Celis J E, ed., Third Edition: Elsevier Inc. Volume 1, pp 425-434.
21. Skasko M, Wang Y, Tian Y, et al. 2011. HIV-1 vpu protein antagonizes innate restriction factor bst-2 via lipid-embedded helix-helix interactions. J Biol Chem, 287(1): 58-67.
22. Terwilliger E F, Cohen E A, Lu Y C, et al. 1989. Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A, 86(13): 5163-5167. (Pubitemid 19182254)
23. Tokarev A, Skasko M, Fitzpatrick K, et al. 2009. Antiviral activity of the interferon-induced cellular protein bst-2/tetherin. AIDS Res Hum Retroviruses, 25(12): 1197-1210.
24. Van Damme N, Goff D, Katsura C, et al. 2008. The interferon-induced protein bst-2 restricts hiv-1 release and is downregulated from the cell surface by the viral vpu protein. Cell Host Microbe, 3(4): 245-252. (Pubitemid 351494713)